{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:12:34Z","timestamp":1785143554235,"version":"3.55.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Macrohormones also called macromolecules or macrocomplexes are described as an antigen-antibody complex, consisting of monomeric hormones bound to immunoglobulins. These molecules exhibit minimal or no biological activity. However, their presence may falsely indicate elevation of active hormones levels which can lead to significant diagnostic challenges. Currently, polyethylene glycol precipitation (PEG) is one of the most recognized methods for identifying macrohormones and it has been widely used in diagnosing macroprolactinemia as awareness of its clinical implications is well recognized. Macrohormone assessment is particularly recommended when clinical symptoms are incompatible with laboratory findings, as it may help avoid unnecessary diagnostic procedures and treatments. Recently, there has been an increasing number of reports highlighting diagnostic challenges associated with other macrohormones, including macro-TSH, macro-FSH, macro-LH, macro-PTH, macro-GH, macro-ACTH, macro-insulin, and macro-calcitonin. The presence of these molecules can lead to overdiagnosis. This review aims to summarize the latest findings and highlight the importance of considering the presence of macrohormones in patients with discrepancies between clinical presentation and hormonal laboratory tests.<\/jats:p>","DOI":"10.3389\/fendo.2026.1913010","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T08:43:36Z","timestamp":1785141816000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Macrohormones in endocrinology: prevalence, clinical impact, and diagnostic approaches"],"prefix":"10.3389","volume":"17","author":[{"given":"Agata","family":"Bronis\u0142awska","sequence":"first","affiliation":[{"name":"Student Scientific Association of Endocrinology, Faculty of Medicine, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Cyran-Sta\u0144czak","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gda\u0144sk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Center","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bronis\u0142awski","sequence":"additional","affiliation":[{"name":"Student Scientific Association of Endocrinology, Faculty of Medicine, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Solecka","sequence":"additional","affiliation":[{"name":"Student Scientific Association of Endocrinology, Faculty of Medicine, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Berli\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gda\u0144sk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Center","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"\u015awi\u0105tkowska-Stodulska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gda\u0144sk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Center","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw Piotr","family":"Jendrzejewski","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gda\u0144sk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Center","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90448-6","article-title":"Macroprolactinemia presenting like a pituitary tumor","volume":"78","author":"Jackson","year":"1985","journal-title":"Am J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-2-258","article-title":"Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses*","volume":"61","author":"Jackson","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1330463","article-title":"Anti-prolactin autoantibodies and hyperprolactinaemia","volume":"133","author":"Olukoga","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06871","article-title":"Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia","volume":"190","author":"Hattori","year":"2006","journal-title":"J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EDM-23-0144","article-title":"Macro-FSH is a rare cause of inappropriately high FSH concentrations","volume":"2024","author":"Mantovani","year":"2024","journal-title":"Endocrinology Diabetes Metab Case Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2022.01.001","article-title":"Macroprolactin: From laboratory to clinical practice","volume":"69","author":"Biagetti","year":"2022","journal-title":"Endocrinolog\u00eda Diabetes Y Nutrici\u00f3n (English ed)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2013.07.002","article-title":"Determination of prolactin: The macroprolactin problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B8","article-title":"The detection of macroprolactin by precipitation and ultrafiltration methods","volume":"62","author":"Beda-Maluga","year":"2011","journal-title":"Endokrynologia Polska"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)46646-X","article-title":"Bioactivity of prolactin in a woman with an excess of large molecular size prolactin, persistent hyperprolactinemia and spontaneous conception","volume":"38","author":"Andersen","year":"1982","journal-title":"Fertility Sterility"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17218199","article-title":"Global prevalence of macroprolactinemia among patients with hyperprolactinemia: A systematic review and meta-analysis","volume":"17","author":"Che Soh","year":"2020","journal-title":"IJERPH"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3137","article-title":"Macrocalcitonin is a novel pitfall in the routine of serum calcitonin immunoassay","volume":"101","author":"Alves","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02049-9","article-title":"Macro-PTH, a rare cause of unexplained elevated serum PTH levels","volume":"46","author":"Cetani","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117392","article-title":"Macro-GH \u2013 A clinical entity causing a diagnostic challenge \u2013 A case report","volume":"546","author":"Stelmachowska-Bana\u015b","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-1149","article-title":"A rare case of both macro-TSH and macro-LH: laboratory analysis of the pathogenesis","volume":"61","author":"Nishiyama","year":"2023","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"EP692","DOI":"10.1530\/endoabs.90.EP692","article-title":"Macrohormones (\u201cincidental hormones\u201d) - a diagnostic challenge in endocrinology: macro-ACTH","volume":"90","author":"Vanuga","year":"2023","journal-title":"Endocrine Abstracts"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2022.80034","article-title":"Insulin autoimmune syndrome without hypoglycemia: A different perspective of method interference","volume":"11","author":"Yesildal","year":"2024","journal-title":"North Clin Istanb"},{"key":"B17","article-title":"Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice","volume":"11","author":"Richa","year":"2010","journal-title":"J Reprod Infertil"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.020","article-title":"Macroprolactinemia: new insights in hyperprolactinemia","volume":"22","author":"Kasum","year":"2012","journal-title":"Biochem Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.065854","article-title":"Specificity and clinical utility of methods for the detection of macroprolactin","volume":"52","author":"Kavanagh","year":"2006","journal-title":"Clin Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfre.2023.05.005","article-title":"Macroprolactinemia: a mini-review and update on clinical practice","volume":"4","author":"Koniares","year":"2023","journal-title":"F&S Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15179","article-title":"PEG precipitation to detect macro\u2010TSH in clinical practice: A systematic review","volume":"102","author":"Piticchio","year":"2025","journal-title":"Clin Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2001-011943","article-title":"Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2021.122723","article-title":"Optimization of a screening method for macroprolactinemia","volume":"1175","author":"Yang","year":"2021","journal-title":"J Chromatogr B"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3343\/alm.2022.42.1.3","article-title":"Hormone immunoassay interference: A 2021 update","volume":"42","author":"Ghazal","year":"2022","journal-title":"Ann Lab Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2021-1288","article-title":"Interferences in immunoassays: review and practical algorithm","volume":"60","author":"Wauthier","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"B26","article-title":"Interferences in immunoassay","volume":"25","author":"Tate","year":"2004","journal-title":"Clin Biochem Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11102-019-01024-z","article-title":"Biochemical diagnosis in prolactinomas: some caveats","volume":"23","author":"Petersenn","year":"2020","journal-title":"Pituitary"},{"key":"B28","article-title":"Diagnosis and management of hyperprolactinemia","volume":"169","author":"Serri","year":"2003","journal-title":"CMAJ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.103102","article-title":"Overview of hyperprolactinemia: General approach and reproductive health implications","volume":"55","author":"Haidenberg-David","year":"2024","journal-title":"Arch Med Res"},{"key":"B30","first-page":"3","article-title":"Prolactin biology and laboratory measurement: An update on physiology and current analytical issues","volume":"39","author":"Saleem","year":"2018","journal-title":"Clin Biochem Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-0264","article-title":"IgA-type macroprolactin among 130 patients with macroprolactinemia","volume":"63","author":"Ishihara","year":"2025","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B32","article-title":"Macroprolactin screening in 464 patients with hyperprolactinaemia","volume":"44","author":"Lim","year":"2022","journal-title":"Malays J Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020936","article-title":"Macroprolactinemia is clinically important (multiple letters)","volume":"87","author":"Olukoga","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","article-title":"Hyperprolactinemia and antipsychotics: it\u2019s not always what it seems to be","volume":"63","author":"Brandsma","year":"2021","journal-title":"Tijdschr Psychiatr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.jhrs_168_20","article-title":"Persistent idiopathic prolactin elevation merits macroprolactin estimation: A case report and review of literature","volume":"14","author":"Gautam","year":"2021","journal-title":"J Hum Reprod Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.11604\/pamj.2020.36.8.22923","article-title":"Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center","volume":"36","author":"Chutpiboonwat","year":"2020","journal-title":"Pan Afr Med J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4158\/EP15938.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology Disease State Clinical Review: Clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia","volume":"21","author":"Samson SusanbL","year":"2015","journal-title":"Endocrine Pract"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2174\/1871530315666151020101518","article-title":"Correlation between systemic lupus erythematosus activity and plasma levels of monomeric prolactin and macroprolactin","volume":"16","author":"Toffoli Ribeiro","year":"2016","journal-title":"EMIDDT"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1770-6","article-title":"Prevalence and reproductive manifestations of macroprolactinemia","volume":"63","author":"Kalsi","year":"2019","journal-title":"Endocrine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/a-0902-4439","article-title":"Cardiometabolic risk factors in men with elevated macroprolactin content: A pilot study","volume":"129","author":"Krysiak","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0898-5","article-title":"Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study","volume":"53","author":"Krysiak","year":"2016","journal-title":"Endocrine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1555877","article-title":"The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: A pilot study","volume":"123","author":"Krysiak","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12020-009-9304-x","article-title":"Macroprolactinemia, like hyperprolactinemia, may promote platelet activation","volume":"37","author":"Anaforoglu","year":"2010","journal-title":"Endocr"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2024-0235","article-title":"Macroprolactin in mothers and their babies: what is its origin","volume":"62","author":"Nishiyama","year":"2024","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/j.2040-4603.2016.tb00708.x","article-title":"Hypothalamus-pituitary-thyroid axis","volume":"6","author":"Ortiga-Carvalho","year":"2016","journal-title":"Compr Physiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid\u00ae"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: Management of subclinical hypothyroidism","volume":"2","author":"Pearce","year":"2013","journal-title":"Eur Thyroid J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000509184","article-title":"Macro-TSH: A diagnostic challenge","volume":"10","author":"Larsen","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-24-0013","article-title":"MacroTSH: still a big problem for clinicians and clinical biochemists: lessons from a case report","volume":"13","author":"Raverot","year":"2024","journal-title":"Eur Thyroid J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ21-0021","article-title":"A case of macro-TSH consisting of IgA-bound TSH","volume":"68","author":"Fukushita","year":"2021","journal-title":"Endocr J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12643","article-title":"Macro TSH in patients with subclinical hypothyroidism","volume":"83","author":"Hattori","year":"2015","journal-title":"Clin Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-0131","article-title":"Clearance of macro-TSH from the circulation is slower than TSH","volume":"60","author":"Yamada","year":"2022","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/EJE-15-0883","article-title":"Variability in the detection of macro TSH in different immunoassay systems","volume":"174","author":"Hattori","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/0004563213476271","article-title":"An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration","volume":"50","author":"Mills","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0442","article-title":"Anti-thyrotropin autoantibodies in patients with macro-thyrotropin and long-term changes in macro-thyrotropin and serum thyrotropin levels","volume":"27","author":"Hattori","year":"2017","journal-title":"Thyroid\u00ae"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198101293040506","article-title":"Increased high-molecular-weight thyrotropin with impaired biologic activity in a euthyroid man","volume":"304","author":"Spitz","year":"1981","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2011.02212.x","article-title":"Elevated thyroid\u2010stimulating hormone level in a euthyroid neonate caused by macro thyrotropin\u2013IgG complex","volume":"100","author":"Rix","year":"2011","journal-title":"Acta Paediatrica"},{"key":"B60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/thy.2022.0457","article-title":"Prevalence and pathogenesis of macro-thyrotropin in neonates: analysis of umbilical cord blood from 939 neonates and their mothers","volume":"33","author":"Hattori","year":"2023","journal-title":"Thyroid"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-0871","article-title":"A challenging case: highly variable TSH in a mother and her two children","volume":"57","author":"Donadio-Andrei","year":"2019","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.5152\/erp.2023.23242","article-title":"Macro-thyroid-stimulating hormone is a rare cause of elevated thyroid-stimulating hormone levels: two cases and review of the literature","volume":"27","author":"\u015eah \u00dcnal","year":"2023","journal-title":"ERP"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K08E-361","article-title":"Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH","volume":"56","author":"Sakai","year":"2009","journal-title":"Endocr J"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ26-0019","article-title":"Low-affinity IgG-mediated macro-TSH: diagnostic limitations of peak-based gel filtration chromatography\u2014a case report with review of literature","volume":"73","author":"Kasahara","year":"2026","journal-title":"Endocr J"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2021.03.010","article-title":"Luteinizing hormone (LH) formed a complex with an immunoglobulin G caused abnormally high levels of LH: A case report","volume":"93","author":"Umemori","year":"2021","journal-title":"Clin Biochem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3071649","article-title":"Abnormally elevated follicle-stimulating hormone (FSH) level in an infertile woman","volume":"2019","author":"Catteau","year":"2019","journal-title":"Case Rep Endocrinol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312735","article-title":"The roles of luteinizing hormone, follicle-stimulating hormone and testosterone in spermatogenesis and folliculogenesis revisited","volume":"22","author":"Oduwole","year":"2021","journal-title":"IJMS"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(98)00076-0","article-title":"Interpretation of elevated FSH in the regular menstrual cycle","volume":"30","author":"Lambalk","year":"1998","journal-title":"Maturitas"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01191-y","article-title":"Macromolecules detected in highly increased serum luteinizing hormone","volume":"43","author":"Ogura-Ochi","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2019-0846","article-title":"Procedures for the diagnosis of macro-follicle stimulating hormone (FSH) in a patient with high serum FSH concentrations","volume":"58","author":"Chihara","year":"2020","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2010.010044","article-title":"Immunoglobulin interference in serum follicle-stimulating hormone assays: autoimmune and heterophilic antibody interference","volume":"47","author":"Webster","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.024992","article-title":"MacroLH\u201d: anomalous molecular form that behaves as a complex of luteinizing hormone (LH) and igG in a patient with unexpectedly high LH values","volume":"49","author":"Vieira","year":"2003","journal-title":"Clin Chem"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/762541","article-title":"Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone","volume":"2012","author":"Haller-Kikkatalo","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B75","first-page":"41","article-title":"Parathyroid hormone","volume-title":"Advances in Clinical Chemistry","author":"Leung","year":"2021"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2024-0455","article-title":"Spurious parathyroid hormone (PTH) elevation caused by macro-PTH","volume":"62","author":"Lavalleye","year":"2024","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"CC4","DOI":"10.1530\/endoabs.44.CC4","article-title":"Asymptomatic elevated PTH level due to immunoassay interference resulting from Macro-PTH: a case report","volume":"44","author":"Prodan","year":"2016","journal-title":"Endocrine Abstracts"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-25-0097","article-title":"Truly elevated PTH or Ulysses syndrome","volume":"2026","author":"Ramakrishna","year":"2026","journal-title":"Endocrinology Diabetes Metab Case Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1564352","article-title":"Case Report: Falsely elevated PTH level in a young woman caused by immunoassay interference resulting from macro-PTH","volume":"16","author":"Perruolo","year":"2025","journal-title":"Front Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007090981","article-title":"PTH-related peptide (PTHrP) in hypercalcemia","volume":"19","author":"Mundy","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1999.277.5.F665","article-title":"Receptors for PTH and PTHrP: their biological importance and functional properties","volume":"277","author":"Mannstadt","year":"1999","journal-title":"Am J Physiol Renal Physiol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2142","article-title":"Parathyroid hormone-related protein: an update","volume":"97","author":"Wysolmerski","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B83","doi-asserted-by":"publisher","first-page":"EP771","DOI":"10.1530\/endoabs.90.EP771","article-title":"A rare case of macro-ACTH in patient with adrenal incidentaloma","volume":"90","author":"Przybycie\u0144","year":"2023","journal-title":"Endocrine Abstracts"},{"key":"B84","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing\u2019s syndrome: from physiological principles to diagnosis and clinical care","volume":"593","author":"Raff","year":"2015","journal-title":"J Physiol"},{"key":"B85","article-title":"Growth hormone and insulin-like growth factor-1","volume-title":"Frontiers of Hormone Research","author":"Nicholls","year":"2016"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2026-0043","article-title":"The prevalence and etiology of macro-growth hormone (GH)","volume":"64","author":"Ohno","year":"2026","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2024\/8721614","article-title":"Subclinical cushing\u2019s disease with high-molecular-weight forms of adrenocorticotropic hormone production","volume":"2024","author":"Inukai","year":"2024","journal-title":"Case Rep Endocrinol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-6-1296","article-title":"A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of cushing\u2019s disease","volume":"65","author":"Reincke","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13438","article-title":"Understanding negative feedback: Changes in high\u2010molecular\u2010weight adrenocorticotropic hormone in adrenocorticotropic hormone\u2010independent Cushing\u2019s syndrome","volume":"36","author":"Ichinose","year":"2024","journal-title":"J Neuroendocrinol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6583467","article-title":"Ectopic ACTH syndrome emerging 5 years after the diagnosis of neuroendocrine tumor","volume":"2019","author":"Liu","year":"2019","journal-title":"Case Rep Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00557","article-title":"High molecular weight ACTH-precursor presence in a metastatic pancreatic neuroendocrine tumor causing severe ectopic cushing\u2019s syndrome: A case report","volume":"11","author":"Mehta","year":"2020","journal-title":"Front Endocrinol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jecr.2016.05.003","article-title":"Hypoglycemia due to Insulin Autoimmune Syndrome: A rare cause not to be forgotten","volume":"2","author":"Alam","year":"2016","journal-title":"J Clin Trans Endocrinology: Case Rep"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S219438","article-title":"Insulin autoimmune syndrome (Hirata disease): A comprehensive review fifty years after its first description","volume":"13","author":"Cappellani","year":"2020","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1913010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T08:43:38Z","timestamp":1785141818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1913010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":93,"alternative-id":["10.3389\/fendo.2026.1913010"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1913010","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"1913010"}}